Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO‐D registry

Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO‐D registry

Abstract Aim Patients with advanced heart failure (AHF) who are not candidates to advanced therapies have poor prognosis. Some trials have shown that intermittent levosimendan can reduce HF hospitalizations in AHF in the short term. In this real‐life registry, we describe the patterns of use, safety...

Full description

Bibliographic Details
Main Authors: David Dobarro, Víctor Donoso‐Trenado, Eduard Solé‐González, Carlos Moliner‐Abós, José Manuel Garcia‐Pinilla, Silvia Lopez‐Fernandez, Sonia Ruiz‐Bustillo, Carles Diez‐Lopez, Javier Castrodeza, Ana B. Méndez‐Fernández, David Vaqueriza‐Cubillo, Marta Cobo‐Marcos, Javier Tobar, Igor Sagasti‐Aboitiz, Miguel Rodriguez, Vanessa Escolar, Ana Abecia, Pau Codina, Inés Gómez‐Otero, Francisco Pastor, Raquel Marzoa‐Rivas, Eva González‐Babarro, Javier deJuan‐Baguda, María Melendo‐Viu, Fernando deFrutos, José Gonzalez‐Costello
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:ESC Heart Failure
Subjects:
Inotropes
Levosimendan
Palliative care
Advanced heart failure
Online Access:https://doi.org/10.1002/ehf2.14278

Internet

https://doi.org/10.1002/ehf2.14278

Similar Items